These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 6609454

  • 1. Immunomodulation of host resistance by tumor variants.
    Fuji H.
    Transplant Proc; 1984 Apr; 16(2):460-2. PubMed ID: 6609454
    [Abstract] [Full Text] [Related]

  • 2. Clonal variation in tumorigenicity of L1210 lymphoma cells: nontumorigenic variants with an enhanced expression of tumor-associated antigen and Ia antigens.
    Fuji H, Iribe H.
    Cancer Res; 1986 Nov; 46(11):5541-7. PubMed ID: 3489524
    [Abstract] [Full Text] [Related]

  • 3. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L, Fuji H.
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [Abstract] [Full Text] [Related]

  • 4. Dynamics of generation of antigen loss variants from L1210 murine leukemia clones detected by a tumor-specific T-cell clone.
    Nagase F, Rahman SM, Yokochi T, Kawashima K, Isobe K, Yoshida T, Nagura E, Nakashima I.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6494-9. PubMed ID: 3499976
    [Abstract] [Full Text] [Related]

  • 5. Development of host-dependent high-grade tumor-specific immunity through a novel mechanism triggered by the Lyt-2+ tumor-specific T cell clone (K7L) that induces temporal growth of L1210 leukemia-K7L-variant.
    Nagase F, Ueda K, Kawashima K, Jamshedur Rahman SM, Isobe K, Yoshida T, Hasegawa Y, Ando K, Iwamoto T, Nagura E.
    J Immunol; 1987 Apr 01; 138(7):2359-65. PubMed ID: 2951438
    [Abstract] [Full Text] [Related]

  • 6. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
    Fuji H.
    Transplant Proc; 1980 Sep 01; 12(3):388-90. PubMed ID: 6784299
    [Abstract] [Full Text] [Related]

  • 7. Immunization of DBA/2 mice with a T cell hybridoma-derived TsF increases immune resistance to the syngeneic tumors P815 and L1210.
    Steele JK, Singhai R, Stammers AT, Levy JG.
    J Immunol; 1986 Nov 01; 137(9):3025-30. PubMed ID: 3489783
    [Abstract] [Full Text] [Related]

  • 8. Differential tumor immunogenicity of DBA/2 mouse lymphoma L1210 and its sublines. III. Control of host resistance to drug-resistant L1210 sublines by H-2-linked and non-H-2-linked genes.
    Fuji H, Murakami M.
    J Natl Cancer Inst; 1983 Jan 01; 70(1):119-25. PubMed ID: 6296515
    [Abstract] [Full Text] [Related]

  • 9. Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay.
    Fuji H, Mihich E.
    Cancer Res; 1975 Apr 01; 35(4):946-52. PubMed ID: 1090366
    [Abstract] [Full Text] [Related]

  • 10. Helper cells active in the generation of cytotoxicity to a syngeneic tumor.
    Hancock EJ, Kilburn DG, Levy JG.
    J Immunol; 1981 Oct 01; 127(4):1394-7. PubMed ID: 6168688
    [Abstract] [Full Text] [Related]

  • 11. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J, Saffold S, Cao X, Krauss J, Chen W.
    J Immunol; 1998 Nov 15; 161(10):5516-24. PubMed ID: 9820528
    [Abstract] [Full Text] [Related]

  • 12. Participation of T-lymphocytes in the curative effect of a novel synthetic polyamine analogue, N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine, against L1210 leukemia in vivo.
    Bowlin TL, Prakash NJ, Edwards ML, Sjoerdsma A.
    Cancer Res; 1991 Jan 01; 51(1):62-6. PubMed ID: 1988107
    [Abstract] [Full Text] [Related]

  • 13. Improved host defense against L1210 leukemia by deprivation of dietary phenylalanine.
    Pine MJ.
    Nutr Cancer; 1981 Jan 01; 3(2):94-102. PubMed ID: 7346795
    [Abstract] [Full Text] [Related]

  • 14. Inheritance of immunogenicity and metastatic potential in murine cell hybrids from the T-lymphoma ESb08 and normal spleen lymphocytes.
    Larizza L, Schirrmacher V, Stöhr M, Pflüger E, Dzarlieva R.
    J Natl Cancer Inst; 1984 Jun 01; 72(6):1371-81. PubMed ID: 6610070
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.